Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Baldo, Barbara ^a   Soylu, Rana ^a   Petersén, Åsa ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE EXPRESSION; HUNTINGTON CHOREA; HYPOTHALAMUS; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BIOLOGICAL MARKERS; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENETIC VECTORS; HUMANS; HUNTINGTON DISEASE; HYPOTHALAMUS; LYSOSOMES; MALE; MICE; MICE, TRANSGENIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84893427651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083050     Document Type: Article

References (115)

1. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971-983.
2. Ross CA, Tabrizi SJ (2011) Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10: 83-98.
3. Novak MJ, Tabrizi SJ (2011) Huntington's disease: clinical presentation and treatment. Int Rev Neurobiol 98: 297-323.
4. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, et al. (1988) Differential loss of striatal projection neurons in Huntington disease. Proceedings of the National Academy of Sciences of the United States of America 85: 5733-5737.
5. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC (2007) Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry 62: 1341-1346. (Pubitemid 350180721)
6. Paulsen JS (2011) Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 11: 474-483.
7. Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL (2001) Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry 71: 310-314. (Pubitemid 32772526)
8. Rosenblatt A (2007) Neuropsychiatry of Huntington's disease. Dialogues Clin Neurosci 9: 191-197.
9. Wiegand M, Moller AA, Lauer CJ, Stolz S, Schreiber W, et al. (1991) Nocturnal sleep in Huntington's disease. J Neurol 238: 203-208.
10. Popovic V, Svetel M, Djurovic M, Petrovic S, Doknic M, et al. (2004) Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease. European journal of endocrinology/European Federation of Endocrine Societies 151: 451-455.
11. Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, et al. (2005) Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci 25: 157-163. (Pubitemid 40110776)
12. Lalic NM, Maric J, Svetel M, Jotic A, Stefanova E, et al. (2008) Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Archives of neurology 65: 476-480. (Pubitemid 351549955)
13. Goodman AO, Murgatroyd PR, Medina-Gomez G, Wood NI, Finer N, et al. (2008) The metabolic profile of early Huntington's disease-a combined human and transgenic mouse study. Experimental neurology 210: 691-698.
14. Arnulf I, Nielsen J, Lohmann E, Schiefer J, Wild E, et al. (2008) Rapid eye movement sleep disturbances in Huntington disease. Archives of neurology 65: 482-488. (Pubitemid 351549956)
15. Aziz NA, Anguelova GV, Marinus J, van Dijk JG, Roos RA (2010) Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease. European journal of neurology : the official journal of the European Federation of Neurological Societies 17: 1068-1074.
16. Politis M, Pavese N, Tai YF, Tabrizi SJ, Barker RA, et al. (2008) Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain : a journal of neurology 131: 2860-2869.
17. Soneson C, Fontes M, Zhou Y, Denisov V, Paulsen JS, et al. (2010) Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiology of disease 40: 531-543.
18. Hult S, Schultz K, Soylu R, Petersen A (2010) Hypothalamic and neuroendocrine changes in Huntington's disease. Curr Drug Targets 11: 1237-1249.
19. Petersen A, Gabery S (2012) Hypothalamic and Limbic System Changes in Huntington's Disease. Journal of Huntington's Disease: 5-16.
20. Timmers HJ, Swaab DF, van de Nes JA, Kremer HP (1996) Somatostatin 1-12 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington's disease patients. Brain Res 728: 141-148. (Pubitemid 26252805)
21. Petersen A, Gil J, Maat-Schieman ML, Bjorkqvist M, Tanila H, et al. (2005) Orexin loss in Huntington's disease. Hum Mol Genet 14: 39-47. (Pubitemid 40123461)
22. Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, et al. (2008) Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Brain pathology 18: 474-483.
23. Gabery S, Murphy K, Schultz K, Loy CT, McCusker E, et al. (2010) Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses. Acta neuropathologica 120: 777-788.
24. Hult S, Soylu R, Bjorklund T, Belgardt BF, Mauer J, et al. (2011) Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits. Cell Metab 13: 428-439.
25. Hult Lundh S, Nilsson N, Soylu R, Kirik D, Petersen A (2013) Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease. Human molecular genetics.
26. Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, et al. (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28: 6182-6195.
27. Garcia-Arencibia M, Hochfeld WE, Toh PP, Rubinsztein DC (2010) Autophagy, a guardian against neurodegeneration. Seminars in cell & developmental biology 21: 691-698.
28. Metcalf DJ, Garcia-Arencibia M, Hochfeld WE, Rubinsztein DC (2012) Autophagy and misfolded proteins in neurodegeneration. Experimental neurology 238: 22-28.
29. He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annual review of genetics 43: 67-93.
30. Yang Z, Klionsky DJ (2010) Mammalian autophagy: core molecular machinery and signaling regulation. Current opinion in cell biology 22: 124-131.
31. Petersen A, Larsen KE, Behr GG, Romero N, Przedborski S, et al. (2001) Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet 10: 1243-1254. (Pubitemid 32600478)
32. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885-889.
33. Martinez-Vicente M, Talloczy Z, Wong E, Tang G, Koga H, et al. (2010) Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nature neuroscience 13: 567-576.
34. Jeong H, Then F, Melia TJ, Jr., Mazzulli JR, Cui L, et al. (2009) Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137: 60-72.
35. Kegel KB, Kim M, Sapp E, McIntyre C, Castano JG, et al. (2000) Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. The Journal of neuroscience : the official journal of the Society for Neuroscience 20: 7268-7278.
36. Qin ZH, Wang Y, Kegel KB, Kazantsev A, Apostol BL, et al. (2003) Autophagy regulates the processing of amino terminal huntingtin fragments. Human molecular genetics 12: 3231-3244. (Pubitemid 37541069)
37. Qi L, Zhang XD, Wu JC, Lin F, Wang J, et al. (2012) The role of chaperone-mediated autophagy in huntingtin degradation. PloS one 7: e46834.
38. Zheng S, Clabough EB, Sarkar S, Futter M, Rubinsztein DC, et al. (2010) Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet 6: e1000838.
39. Roscic A, Baldo B, Crochemore C, Marcellin D, Paganetti P (2011) Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model. J Neurochem 119: 398-407.
40. Sarkar S, Rubinsztein DC (2008) Huntington's disease: degradation of mutant huntingtin by autophagy. The FEBS journal 275: 4263-4270.
41. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, et al. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36: 585-595. (Pubitemid 38715985)
42. Yamamoto A, Cremona ML, Rothman JE (2006) Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 172: 719-731.
43. Rabinowitz JD, White E (2010) Autophagy and metabolism. Science 330: 1344-1348.
44. Coupe B, Ishii Y, Dietrich MO, Komatsu M, Horvath TL, et al. (2012) Loss of autophagy in pro-opiomelanocortin neurons perturbs axon growth and causes metabolic dysregulation. Cell metabolism 15: 247-255.
45. Kaushik S, Rodriguez-Navarro JA, Arias E, Kiffin R, Sahu S, et al. (2011) Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance. Cell Metab 14: 173-183.
46. Meng Q, Cai D (2011) Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)/NF-kappaB pathway. The Journal of biological chemistry 286: 32324-32332.
47. Quan W, Kim HK, Moon EY, Kim SS, Choi CS, et al. (2012) Role of hypothalamic proopiomelanocortin neuron autophagy in the control of appetite and leptin response. Endocrinology 153: 1817-1826.
48. Harada H, Warabi E, Matsuki T, Yanagawa T, Okada K, et al. (2013) Deficiency of p62/Sequestosome 1 Causes Hyperphagia Due to Leptin Resistance in the Brain. The Journal of neuroscience : the official journal of the Society for Neuroscience 33: 14767-14777.
49. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
50. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nature protocols 3: 1101-1108. (Pubitemid 351818697)
51. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293: 493-498. (Pubitemid 32679077)
52. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, et al. (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127: 59-69. (Pubitemid 44466642)
53. Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, et al. (2006) Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab 4: 349-362. (Pubitemid 44645069)
54. Zucker B, Luthi-Carter R, Kama JA, Dunah AW, Stern EA, et al. (2005) Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1. Human molecular genetics 14: 179-189.
55. Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, et al. (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Human molecular genetics 11: 1911-1926.
56. Chan EY, Luthi-Carter R, Strand A, Solano SM, Hanson SA, et al. (2002) Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. Human molecular genetics 11: 1939-1951. (Pubitemid 34919270)
57. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, et al. (2006) Regional and cellular gene expression changes in human Huntington's disease brain. Human molecular genetics 15: 965-977. (Pubitemid 43338237)
58. Thomas EA, Coppola G, Tang B, Kuhn A, Kim S, et al. (2011) In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons. Human molecular genetics 20: 1049-1060.
59. Tanida I, Ueno T, Kominami E (2004) LC3 conjugation system in mammalian autophagy. The international journal of biochemistry & cell biology 36: 2503-2518. (Pubitemid 39119762)
60. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, et al. (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 169: 425-434. (Pubitemid 40686693)
61. Cao Y, Klionsky DJ (2007) Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell research 17: 839-849. (Pubitemid 47585112)
62. Johansen T, Lamark T (2011) Selective autophagy mediated by autophagic adapter proteins. Autophagy 7: 279-296.
63. Wirawan E, Lippens S, Vanden Berghe T, Romagnoli A, Fimia GM, et al. (2012) Beclin1: a role in membrane dynamics and beyond. Autophagy 8: 6-17.
64. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, et al. (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544.
65. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, et al. (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614. (Pubitemid 41668720)
66. Bartlett BJ, Isakson P, Lewerenz J, Sanchez H, Kotzebue RW, et al. (2011) p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy 7: 572-583.
67. Rue L, Lopez-Soop G, Gelpi E, Martinez-Vicente M, Alberch J, et al. (2013) Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington's disease. Neurobiol Dis 52: 219-228.
68. Yamanaka T, Tosaki A, Miyazaki H, Kurosawa M, Furukawa Y, et al. (2010) Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction. Human molecular genetics 19: 2099-2112.
69. Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neuroscience letters 133: 257-261.
70. Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, et al. (1998) Regional specificity of brain atrophy in Huntington's disease. Experimental neurology 154: 663-672. (Pubitemid 29044235)
71. Pouladi MA, Stanek LM, Xie Y, Franciosi S, Southwell AL, et al. (2012) Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum Mol Genet 21: 2219-2232.
72. Albin RL, Young AB, Penney JB, Handelin B, Balfour R, et al. (1990) Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. The New England journal of medicine 322: 1293-1298. (Pubitemid 20152493)
73. Deng YP, Albin RL, Penney JB, Young AB, Anderson KD, et al. (2004) Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. Journal of chemical neuroanatomy 27: 143-164. (Pubitemid 38739355)
74. Kelley AE, Baldo BA, Pratt WE (2005) A proposed hypothalamic- thalamicstriatal axis for the integration of energy balance, arousal, and food reward. The Journal of comparative neurology 493: 72-85. (Pubitemid 41636189)
75. Kelley AE, Baldo BA, Pratt WE, Will MJ (2005) Corticostriatal- hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiology & behavior 86: 773-795. (Pubitemid 41728993)
76. Weihl CC (2013) Monitoring autophagy in the treatment of protein aggregate diseases: steps toward identifying autophagic biomarkers. Neurotherapeutics 10: 383-390.
77. Jiang M, Wang J, Fu J, Du L, Jeong H, et al. (2012) Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nature medicine 18: 153-158.
78. Zala D, Hinckelmann MV, Yu H, Lyra da Cunha MM, Liot G, et al. (2013) Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 152: 479-491.
79. Kremer HP, Roos RA (1992) Weight loss in Huntington's disease. Archives of neurology 49: 349.
80. Trejo A, Tarrats RM, Alonso ME, Boll MC, Ochoa A, et al. (2004) Assessment of the nutrition status of patients with Huntington's disease. Nutrition 20: 192-196. (Pubitemid 38220981)
81. Farrer LA (1985) Diabetes mellitus in Huntington disease. Clinical genetics 27: 62-67.
82. Block RC, Dorsey ER, Beck CA, Brenna JT, Shoulson I (2010) Altered cholesterol and fatty acid metabolism in Huntington disease. Journal of clinical lipidology 4: 17-23.
83. Van Raamsdonk JM, Gibson WT, Pearson J, Murphy Z, Lu G, et al. (2006) Body weight is modulated by levels of full-length huntingtin. Hum Mol Genet 15: 1513-1523.
84. Singh R (2012) Autophagy in the control of food intake. Adipocyte 1: 75-79.
85. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880-884.
86. Martinez-Vicente M, Cuervo AM (2007) Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 6: 352-361. (Pubitemid 46367949)
87. Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075. (Pubitemid 351317450)
88. Jimenez-Sanchez M, Thomson F, Zavodszky E, Rubinsztein DC (2012) Autophagy and polyglutamine diseases. Prog Neurobiol 97: 67-82.
89. Proenca CC, Stoehr N, Bernhard M, Seger S, Genoud C, et al. (2013) Atg4b-Dependent Autophagic Flux Alleviates Huntington's Disease Progression. PloS one 8: e68357.
90. Sarkar S, Krishna G, Imarisio S, Saiki S, O'Kane CJ, et al. (2008) A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. Human molecular genetics 17: 170-178.
91. Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, et al. (2007) Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 3: 331-338. (Pubitemid 46789270)
92. Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC (2009) Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine- expanded huntingtin and related proteinopathies. Cell Death Differ 16: 46-56.
93. Mizushima N, Klionsky DJ (2007) Protein turnover via autophagy: implications for metabolism. Annual review of nutrition 27: 19-40. (Pubitemid 351373346)
94. Heng MY, Duong DK, Albin RL, Tallaksen-Greene SJ, Hunter JM, et al. (2010) Early autophagic response in a novel knock-in model of Huntington disease. Hum Mol Genet 19: 3702-3720.
95. Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, et al. (2000) A ubiquitin-like system mediates protein lipidation. Nature 408: 488-492.
96. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, et al. (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. The Journal of cell biology 169: 425-434. (Pubitemid 40686693)
97. Metzger S, Saukko M, Van Che H, Tong L, Puder Y, et al. (2010) Age at onset in Huntington's disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7. Hum Genet 128: 453-459.
98. Shibata M, Lu T, Furuya T, Degterev A, Mizushima N, et al. (2006) Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. The Journal of biological chemistry 281: 14474-14485. (Pubitemid 43848378)
99. Wu JC, Qi L, Wang Y, Kegel KB, Yoder J, et al. (2012) The regulation of Nterminal Huntingtin (Htt552) accumulation by Beclin1. Acta pharmacologica Sinica 33: 743-751.
100. Koga H, Cuervo AM (2011) Chaperone-mediated autophagy dysfunction in the pathogenesis of neurodegeneration. Neurobiology of disease 43: 29-37.
101. Koga H, Martinez-Vicente M, Arias E, Kaushik S, Sulzer D, et al. (2011) Constitutive upregulation of chaperone-mediated autophagy in Huntington's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience 31: 18492-18505.
102. Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nature reviews Molecular cell biology 12: 21-35.
103. Lundh SH, Soylu R, Petersen A (2012) Expression of Mutant Huntingtin in Leptin Receptor-Expressing Neurons Does Not Control the Metabolic and Psychiatric Phenotype of the BACHD Mouse. PLoS One 7: e51168.
104. Wu J, Dang Y, Su W, Liu C, Ma H, et al. (2006) Molecular cloning and characterization of rat LC3A and LC3B-two novel markers of autophagosome. Biochemical and biophysical research communications 339: 437-442. (Pubitemid 41697567)
105. He H, Dang Y, Dai F, Guo Z, Wu J, et al. (2003) Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. The Journal of biological chemistry 278: 29278-29287. (Pubitemid 36935844)
106. Romanov J, Walczak M, Ibiricu I, Schuchner S, Ogris E, et al. (2012) Mechanism and functions of membrane binding by the Atg5-Atg12/Atg16 complex during autophagosome formation. The EMBO journal 31: 4304-4317.
107. Kang R, Zeh HJ, Lotze MT, Tang D (2011) The Beclin 1 network regulates autophagy and apoptosis. Cell death and differentiation 18: 571-580.
108. Lamark T, Kirkin V, Dikic I, Johansen T (2009) NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell cycle 8: 1986-1990.
109. Kirkin V, Lamark T, Johansen T, Dikic I (2009) NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets. Autophagy 5: 732-733.
110. Arias E, Cuervo AM (2011) Chaperone-mediated autophagy in protein quality control. Current opinion in cell biology 23: 184-189.
111. Eskelinen EL, Illert AL, Tanaka Y, Schwarzmann G, Blanz J, et al. (2002) Role of LAMP-2 in lysosome biogenesis and autophagy. Molecular biology of the cell 13: 3355-3368. (Pubitemid 35034269)
112. Foster KG, Fingar DC (2010) Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. The Journal of biological chemistry 285: 14071-14077.
113. Jung CH, Ro SH, Cao J, Otto NM, Kim DH (2010) mTOR regulation of autophagy. FEBS letters 584: 1287-1295.
114. Dunlop EA, Tee AR (2009) Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cellular signalling 21: 827-835.
115. Alessi DR, Pearce LR, Garcia-Martinez JM (2009) New insights into mTOR signaling: mTORC2 and beyond. Science signaling 2: pe27.